1.4. Analysis.
Comparison 1: Daily cotrimoxazole (CTXp) with any other drug regimen (mefloquine (MQ) or dihydroartemisinin‐piperaquine (DHA‐PPQ)) versus CTXp with or without placebo (current standard of care), Outcome 4: Placental malaria (any test)
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.